glp 1 malnutrition Nutritional Deficiencies with weekly GLP-1 Receptor Agonists (Ozempic & Mounjaro): What patients Need to GLP-1 and Alzheimer's Disease: Research

Andy Cohen explained why he recently began microdosing a GLP-1.

But as clinical data mature, an important question has emerged: What happens to lean muscle mass during rapid weight reduction

Ozempics Patent Protection Starts to Expire in 2026

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with adverse outcomes such as cirrhosis, malignancy, transplantation, and mortality